Clinical Trials Logo

Medical Abortion clinical trials

View clinical trials related to Medical Abortion.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05119439 Terminated - Medical Abortion Clinical Trials

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Start date: October 7, 2022
Phase: Phase 4
Study type: Interventional

This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.

NCT ID: NCT04941443 Terminated - Pain Clinical Trials

Methadone and Medication Abortion

Start date: October 4, 2021
Phase: Phase 4
Study type: Interventional

Pain has been recognized to be the most common and predictable side effect of medication abortion, causing significant distress associated with the process. Yet there is little known about the appropriate management of pain during this process, with no current evidence based recommendations for optimal analgesic regimens during the first trimester. The goal of this study is to evaluate the efficacy of oral methadone for pain control during medication abortion. The current medication regimen used to perform medication abortion is a dose of mifepristone (antiprogesterone) orally, followed by a dose of misoprostol (prostaglandin analogue) 24 to 72 hours later. Patients are prescribed a standard dose of ibuprofen 600-800mg tabs for pain control during the process. The investigators will conduct a non-randomized, pilot study with 25 patients evaluated at the Boston Medical Center family planning clinic at 10 weeks of gestation or less for medication abortion.